amitrole has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Amitrole: A non-selective post-emergence, translocated herbicide. According to the Seventh Annual Report on Carcinogens (PB95-109781, 1994) this substance may reasonably be anticipated to be a carcinogen. (From Merck Index, 12th ed) It is an irreversible inhibitor of CATALASE, and thus impairs activity of peroxisomes.
amitrole : A member of the class of triazoles that is 1H-1,2,4-triazole substituted by an amino group at position 3. Used to control annual grasses and aquatic weeds (but not on food crops because it causes cancer in laboratory animals). Its use within the EU was banned from September 2017 on the grounds of potential groundwater contamination and risks to aquatic life; there have also been concerns about its endocrine-disrupting properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwee, JK | 1 |
| Luque, DG | 1 |
| Ferreira, AC | 1 |
| Vasconcelos, FC | 1 |
| Silva, KL | 1 |
| Klumb, CE | 1 |
| Maia, RC | 1 |
1 other study available for amitrole and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Modulation of reactive oxygen species by antioxidants in chronic myeloid leukemia cells enhances imatinib sensitivity through survivin downregulation.
Topics: Amitrole; Antineoplastic Agents; Antioxidants; Benzamides; Buthionine Sulfoximine; Dose-Response Rel | 2008 |